title: Reduction in endogenous parkin levels renders glial cells sensitive to both caspase-dependent and caspase-independent cell death.
authors.affiliation: Medical Molecular Biology Unit, Institute of Child Health, University College London, Guilford Street, London, UK.
authors.forename: Luci P
authors.initials: LP
authors.lastname: MacCormac
authors.forename: Miratul M K
authors.initials: MM
authors.lastname: Muqit
authors.forename: David J
authors.initials: DJ
authors.lastname: Faulkes
authors.forename: Nicholas W
authors.initials: NW
authors.lastname: Wood
authors.forename: David S
authors.initials: DS
authors.lastname: Latchman
mesh_terms: D000818:Animals; D061945:Caspase Inhibitors; D020169:Caspases / Q000378:metabolism*; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D004298:Dopamine / Q000494:pharmacology; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D009457:Neuroglia / Q000187:drug effects / Q000201:enzymology*; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
chemical_list: D061945:Caspase Inhibitors; D011480:Protease Inhibitors; D006861:Hydrogen Peroxide; D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; D020169:Caspases; D004298:Dopamine